Kidney fibrosis: from mechanisms to therapeutic medicines

Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a hallmark manifestation in different progressive CKD; However, at present no antifibrotic therapies against CKD exist....

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rongshuang, Fu, Ping, Ma, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023808/
https://www.ncbi.nlm.nih.gov/pubmed/36932062
http://dx.doi.org/10.1038/s41392-023-01379-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023808/
https://www.ncbi.nlm.nih.gov/pubmed/36932062
http://dx.doi.org/10.1038/s41392-023-01379-7

Ejemplares similares